-
iShares U.S. Healthcare Providers ETF (IHF $48.52)
- $48.52 P/E (TTM): 17.33X Cap: $796M
- View IHF Profile
- View Questions on IHF
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
iShares U.S. Healthcare Providers ETF (IHF $48.52)
- $48.52 P/E (TTM): 17.33X Cap: $796M
- View IHF Profile
- View Questions on IHF
-
Elevance Health Inc. (ELV $317.89)
- $317.89 P/E (TTM): 13.31X Cap: $71.58B
- View ELV Profile
- View Questions on ELV
Q: On Oct 22, concerning ELV's quarterly results, you said, "a key issue was the 'timing mismatch' between Medicaid reimbursement rates and the higher healthcare needs of members" - an issue linked to post-COVID resumption of full-service healthcare.
But isn't this a case of 'one-off' cyclicality in an industry which was assumed to be secular? In which case, doesn't ELV become mis-priced as reimbursements and higher needs fall back into balance?
Finally, to operationalize this strategy, would it be preferable to seek-out the most beaten-down health insurer (perhaps you have suggestions), or to pick something like IHF (ditto)?
But isn't this a case of 'one-off' cyclicality in an industry which was assumed to be secular? In which case, doesn't ELV become mis-priced as reimbursements and higher needs fall back into balance?
Finally, to operationalize this strategy, would it be preferable to seek-out the most beaten-down health insurer (perhaps you have suggestions), or to pick something like IHF (ditto)?
-
AbbVie Inc. (ABBV $222.59)
- $222.59 P/E (TTM): 106.44X Cap: $393.21B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $174.21)
- $174.21 P/E (TTM): 18.84X Cap: $419.55B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $754.95)
- $754.95 P/E (TTM): 49.15X Cap: $714.52B
- View LLY Profile
- View Questions on LLY
-
Thermo Fisher Scientific Inc (TMO $474.99)
- $474.99 P/E (TTM): 27.74X Cap: $179.36B
- View TMO Profile
- View Questions on TMO
-
UnitedHealth Group Incorporated (DE) (UNH $341.30)
- $341.30 P/E (TTM): 14.09X Cap: $309.10B
- View UNH Profile
- View Questions on UNH
-
Novo Nordisk A/S (NVO $60.71)
- $60.71 P/E (TTM): 17.26X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
iShares U.S. Medical Devices ETF (IHI $60.51)
- $60.51 P/E (TTM): 28.17X Cap: $4.25B
- View IHI Profile
- View Questions on IHI
-
iShares U.S. Healthcare Providers ETF (IHF $48.52)
- $48.52 P/E (TTM): 17.33X Cap: $796M
- View IHF Profile
- View Questions on IHF
Q: Hi,
I would like to put some money in US healthcare. What do you think of these ideas?Would you pick one or a couple?
I would like to put some money in US healthcare. What do you think of these ideas?Would you pick one or a couple?
Insiders
Share Information
SEC Filings
News and Media